Biotech investors are once again rotating aggressively into clinical-stage growth stories as a fresh wave of capital ...

Vir Biotechnology develops antibody and RNA-based therapies for infectious diseases, leveraging partnerships and a robust ...

Research Alliance III follows a few months after Cormorant Asset Management priced a $150 million IPO for its own blank-check ...

Researchers have introduced a new biotechnology platform that may help the petrochemical industry rely less on ...

Vir Biotechnology develops immunology-based therapies for infectious diseases, backed by collaborations and a diversified ...

Focused on immunology-based therapies for infectious diseases, this biotech company reported a notable insider sale in recent ...

On this week’s episode of “The Readout LOUD,” the hosts discuss STAT's Breakthrough Summit West, where powerful leaders from ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

Launched with NSF funding this year, Penn’s AIRFoundry boasts the potential to radically speed up drug development.

Microbial biotechnology is a dynamic field, The origins of microbiology can be traced back to the pioneering research by scientists such as Louis Pasteur and Robert Koch in the 19 th century. Within a ...

JPMorgan has reinstated coverage and price targets on 14 major biotechnology companies, signaling renewed confidence in the ...